Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors

European Journal of Immunology

Volumn 38, Issue 11, 2008, Pages 3041-3049

  Kiss, Jan ^a,b   Jalkanen, Sirpa ^a,c   Fülöp, Ferenc ^d   Savunen, Timo ^b   Salmi, Marko ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adhesion molecules; Inflammation; Ischemia reperfusion injury

Indexed keywords

MONOCLONAL ANTIBODY; VASCULAR ADHESION PROTEIN 1; AMINE OXIDASE (COPPER CONTAINING); AOC3 PROTEIN, HUMAN; CELL ADHESION MOLECULE; SEMICARBAZIDE SENSITIVE AMINE OXIDASE VASCULAR ADHESION PROTEIN 1, MOUSE; SEMICARBAZIDE-SENSITIVE AMINE OXIDASE-VASCULAR ADHESION PROTEIN-1, MOUSE; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; INTESTINE INJURY; INTESTINE ISCHEMIA; LEUKOCYTE ACTIVATION; LUNG SEQUESTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; IMMUNOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ACUTE LUNG INJURY; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; ANTIBODIES, MONOCLONAL; CATALYSIS; CELL ADHESION MOLECULES; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REPERFUSION INJURY;

EID: 58149349910     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838651     Document Type: Article

References (46)

1. Ley, K., Laudanna, C., Cybulsky, M. I. and Nourshargh, S., Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007. 7: 678-689.
2. Brown, K. A., Brain, S. D., Pearson, J. D., Edgeworth, J. D., Lewis, S. M. and Treacher, D. F., Neutrophils in development of multiple organ failure in sepsis. Lancet 2006. 368: 157-169.
3. Luster, A. D. and Tager, A. M., T-cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 2004. 4: 711-724.
4. Reutershan, J. and Ley, K., Bench-to-bedside review: Acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit. Care 2004. 8: 453-461.
5. Vinten-Johansen, J., Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 2004. 61: 481-497.
6. Carden, D. L. and Granger, D. N., Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 2000. 190: 255-266.
7. Ichikawa, H., Flores, S., Kvietys, P. R., Wolf, R. E., Yoshikawa, T., Granger, D. N. and Aw, T. Y., Molecular mechanisms of anoxia/ reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ. Res. 1997. 81: 922-931.
8. van Eeden, S. F., Kitagawa, Y., Klut, M. E., Lawrence, E. and Hogg, J. C., Polymorphonuclear leukocytes released from the bone marrow preferentially sequester in lung microvessels. Microcirculation 1997. 4: 369-380.
9. Zhang, H., Porro, G., Orzech, N., Mullen, B., Liu, M. and Slutsky, A. S., Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am. J. Physiol. Lung Cell Mol. Physiol. 2001. 280: L947-L954.
10. Guidet, B., Aegerter, P., Gauzit, R., Meshaka, P. and Dreyfuss, D., Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005. 127: 942-951.
11. Salmi, M. and Jalkanen, S., A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992. 257: 1407-1409.
12. Salmi, M., Kalimo, K. and Jalkanen, S., Induction and function of vascular adhesion protein-1 at sites of inflammation. J. Exp. Med. 1993. 178: 2255-2260.
13. Smith, D. J., Salmi, M., Bono, P., Hellman, J., Leu, T. and Jalkanen, S., Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 1998. 188: 17-27.
14. Klinman, J. P. and Mu, D., Quinoenzymes in biology. Annu. Rev. Biochem. 1994. 63: 299-344.
15. Jalkanen, S. and Salmi, M., Cell surface monoamine oxidases: enzymes in search of a function. EMBO J. 2001. 20: 3893-3901.
16. Yu, P. H., Wright, S., Fan, E. H., Lun, Z. R. and Gubisne-Harberle, D., Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim. Biophys. Acta 2003. 1647: 193-199.
17. Jalkanen, S. and Salmi, M., VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler. Thromb. Vasc. Biol. 2008. 28: 18-26.
18. Salmi, M. and Jalkanen, S., Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 2005. 5: 760-771.
19. Bonder, C. S., Norman, M. U., Swain, M. G., Zbytnuik, L. D., Yamanouchi, J., Santamaria, P., Ajuebor, M. et al., Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: A role for alpha-4 integrin and vascular adhesion protein-1. Immunity 2005. 23: 153-163.
20. Koskinen, K., Vainio, P. J., Smith, D. J., Pihlavisto, M., Yla-Herttuala, S., Jalkanen, S. and Salmi, M., Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood 2004. 103: 3388-3395.
21. Stolen, C. M., Marttila-Ichihara, F., Koskinen, K., Yegutkin, G. G., Turja, R., Bono, P., Skurnik, M. et al., Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 2005. 22: 105-115.
22. Koskinen, K., Nevalainen, S., Karikoski, M., Hanninen, A., Jalkanen, S. and Salmi, M., VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: Implications for antiadhesive applications. J. Immunol. 2007. 179: 6160-6168.
23. Marttila-Ichihara, F., Smith, D. J., Stolen, C., Yegutkin, G. G., Elima, K, Mercier N., Kiviranta, R. et al., Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo. Arthritis Rheum. 2006. 54: 2852-2862.
24. Ohara, M., Unno, N., Mitsuoka, H., Kaneko, H. and Nakamura, S., Peritoneal lavage with oxygenated perfluorochemical preserves intestinal mucosal barrier function after ischemia-reperfusion and ameliorates lung injury. Crit. Care Med. 2001. 29: 782-788.
25. Kiss, J., Yegutkin, G. G., Koskinen, K., Savunen, T., Jalkanen, S. and Salmi, M., IFN-beta protects from vascular leakage via up-regulation of CD73. Eur. J. Immunol. 2007. 37: 3334-3338.
26. Jaakkola, K., Nikula, T., Holopainen, R., Vahasilta, T., Matikainen, M. T., Laukkanen, M. L., Huupponen, R. et al., In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am. J. Pathol. 2000. 157: 463-471.
27. Kakkar, A. K. and Lefer, D. J., Leukocyte and endothelial adhesion molecule studies in knockout mice. Curr. Opin. Pharmacol. 2004. 4: 154-158.
28. Jones, S. P., Trocha, S. D., Strange, M. B., Granger, D. N., Kevil, C. G., Bullard, D. C. and Lefer, D. J., Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2000. 279: H2196-H2201.
29. Abraham, E., Carmody, A., Shenkar, R. and Arcaroli, J., Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2000. 279: L1137-L1145.
30. Kamochi, M., Kamochi, F., Kim, Y. B., Sawh, S., Sanders, J. M., Sarembock, I., Green, S. et al., P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am. J. Physiol. 1999. 277: L310-L319.
31. Eckle, T., Fullbier, L., Wehrmann, M., Khoury, J., Mittelbronn, M., Ibla, J., Rosenberger, P. and Eltzschig, H. K., Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 2007. 178: 8127-8137.
32. Salmi, M., Yegutkin, G. G., Lehvonen, R., Koskinen, K., Salminen, T. and Jalkanen, S., A cell surface amine oxidase directly controls lymphocyte migration. Immunity. 2001. 14: 265-276.
33. Lalor, P. F., Edwards, S., McNab, G., Salmi, M., Jalkanen, S. and Adams, D. H., Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J. Immunol. 2002. 169: 983-992.
34. Jalkanen, S., Karikoski, M., Mercier, N., Koskinen, K., Henttinen, T., Elima, K., Salmivirta, K. and Salmi, M., The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 2007. 110: 1864-1870.
35. Lalor, P. F., Sun, P. J., Weston, C. J., Martin-Santos, A., Wakelam, M. J. and Adams, D. H., Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion. Hepatology 2007. 45: 465-474.
36. Sole, M., Hernandez-Guillamon, M., Boada, M. and Unzeta, M., p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1. Biochim. Biophys. Acta 2008. 1783: 1085-1094.
37. Chassande, O., Renard, S., Barbry, P. and Lazdunski, M., The human gene for diamine oxidase, an amiloride binding protein. Molecular cloning, sequencing, and characterization of the promoter. J. Biol. Chem. 1994. 269: 14484-14489.
38. Imamura, Y., Noda, S., Mashima, Y., Kudoh, J., Oguchi, Y. and Shimizu, N., Human retina-specific amine oxidase: Genomic structure of the gene (AOC2), alternatively spliced variant, and mRNA expression in retina. Genomics 1998. 51: 293-298.
39. Xu, H. L., Salter-Cid, L., Linnik, M. D., Wang, E. Y., Paisansathan, C. and Pelligrino, D. A., Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogentreated ovariectomized female rats subjected to transient forebrain ischemia. J. Pharmacol. Exp. Ther. 2006. 317: 19-29.
40. Yu, P. H., Lu, L. X., Fan, H., Kazachkov, M., Jiang, Z. J., Jalkanen, S. and Stolen, C., Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation. Am. J. Pathol. 2006. 168: 718-726.
41. O'Rourke, A. M., Wang, E. Y., Miller, A., Podar, E. M., Scheyhing, K., Huang, L., Kessler, C. et al., Anti-inflammatory effects of LJP 1586, an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity. J. Pharmacol. Exp. Ther. 2007. 334: 867-875.
42. Stolen, C. M., Marttila-Ichihara, F., Koskinen, K., Yegutkin, G. G., Turja, R., Bono, P., Skurnik, M. et al., Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity. 2005. 22: 105-115.
43. Kirton, C. M., Laukkanen, M. L., Nieminen, A., Merinen, M., Stolen, C. M., Armour, K., Smith, D. J. et al., Function-blocking antibodies to human vascular adhesion protein-1: A potential anti-inflammatory therapy. Eur. J. Immunol. 2005. 35: 3119-3130.
44. Bono, P., Salmi, M., Smith, D. J. and Jalkanen, S., Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J. Immunol. 1998. 160: 5563-5571.
45. Bono, P., Jalkanen, S. and Salmi, M., Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. Am. J. Pathol. 1999. 155: 1613-1624.
46. Park, P. O., Haglund, U., Bulkley, G. B. and Falt, K., The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 1990. 107: 574-580.